CONCLUSIONS: TARGET demonstrated that ceftobiprole is noninferior to vancomycin/aztreonam in the treatment of ABSSSIs, in terms of early clinical response and investigator-assessed clinical success at the TOC visit.
Low Vancomycin trough concentration in neonates and young infants.
Pediatr Int. 2020 Sep 07;:
Authors: Maruyama H, Tanzawa A, Funaki T, Ito Y, Isayama T